Related Experiment Video
Updated: May 11, 2026
On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial
Fedir N Kiskin1, Yuan Yang1, Hao Yang1
1Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen 518132, China.
Insights
Human pluripotent stem cell-derived endothelial cells (hPSC-ECs) offer insights into genetic cardiovascular diseases. Challenges remain in using hPSC-ECs for complex diseases and precision medicine drug screening.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Endothelial Cell Biology
Background:
- Endothelial dysfunction is key in cardiovascular diseases, marked by reduced nitric oxide and increased inflammation.
- Human pluripotent stem cell-derived endothelial cells (hPSC-ECs) are valuable for studying genetic cardiovascular conditions.
- Complex multifactorial diseases like atherosclerosis present challenges for current hPSC-EC models.
Purpose of the Study:
- To review methods for generating and characterizing hPSC-ECs.
- To assess hPSC-EC effectiveness in cardiovascular disease modeling and drug screening.
- To explore obstacles hindering hPSC-EC application in precision medicine.
Main Methods:
- Review of literature on hPSC-EC generation and characterization techniques.
- Assessment of existing studies utilizing hPSC-ECs for disease modeling.
- Analysis of high-throughput drug screening applications using hPSC-ECs.
Main Results:
- hPSC-ECs provide novel insights into genetically driven cardiovascular diseases.
- Significant challenges exist in applying hPSC-ECs to complex multifactorial cardiovascular diseases.
- Current methods and applications of hPSC-ECs in cardiovascular research are detailed.
Conclusions:
- hPSC-ECs show promise for patient-specific precision medicine in cardiovascular diseases.
- Overcoming current obstacles is crucial for realizing the full potential of hPSC-ECs.
- Further advancements are needed to fully leverage hPSC-ECs for understanding and treating intricate cardiovascular conditions.
Abstract:
Endothelial dysfunction is a central contributor to the development of most cardiovascular diseases and is characterised by the reduced synthesis or bioavailability of the vasodilator nitric oxide together with other abnormalities such as inflammation, senescence, and oxidative stress. The use of patient-specific and genome-edited human pluripotent stem cell-derived endothelial cells (hPSC-ECs) has shed novel insights into the role of endothelial dysfunction in cardiovascular diseases with strong genetic components such as genetic cardiomyopathies and pulmonary arterial hypertension. However, their utility in studying complex multifactorial diseases such as atherosclerosis, metabolic syndrome and heart failure poses notable challenges. In this review, we provide an overview of the different methods used to generate and characterise hPSC-ECs before comprehensively assessing their effectiveness in cardiovascular disease modelling and high-throughput drug screening. Furthermore, we explore current obstacles that will need to be overcome to unleash the full potential of hPSC-ECs in facilitating patient-specific precision medicine. Addressing these challenges holds great promise in advancing our understanding of intricate cardiovascular diseases and in tailoring personalised therapeutic strategies.
